KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clorox (CLX) Gains from Investment Securities (2016 - 2025)

Clorox has reported Gains from Investment Securities over the past 16 years, most recently at -$13.0 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 30.0% year-over-year to -$13.0 million; the TTM value through Mar 2026 reached -$8.0 million, down 900.0%, while the annual FY2025 figure was $2.0 million, 107.69% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$13.0 million at Clorox, down from $12.0 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $107.0 million in Q2 2023 and troughed at -$33.0 million in Q1 2023.
  • A 5-year average of $5.9 million and a median of -$4.0 million in 2021 define the central range for Gains from Investment Securities.
  • On a YoY basis, Gains from Investment Securities climbed as much as 1600.0% in 2022 and fell as far as 500.0% in 2022.
  • Year by year, Gains from Investment Securities stood at -$1.0 million in 2021, then skyrocketed by 1600.0% to $15.0 million in 2022, then plummeted by 226.67% to -$19.0 million in 2023, then skyrocketed by 47.37% to -$10.0 million in 2024, then fell by 30.0% to -$13.0 million in 2025.
  • Business Quant data shows Gains from Investment Securities for CLX at -$13.0 million in Q4 2025, $12.0 million in Q3 2025, and -$7.0 million in Q2 2025.